Clinical Trial Update: Evaluation of the Safety, Pharmacokinetics, and Preliminary Effect on Scar Formation by RXI-109 [Phase 1]

View source ↗

Summary

Phase 1 trial update for RXI-109 assessing safety, pharmacokinetics, and preliminary effects on scar formation (cicatrix).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scar

Drugs mentioned

• RXI-109 (RXI-109)

Snippet

Sponsor: RXi Pharmaceuticals, Corp. | Conditions: Cicatrix, Scar Prevention | Phase 1 | Status: COMPLETED